Fondamenti scientifici del programma InnGevity® CLINIC

Il programma InnGevity® CLINIC si fonda su solide basi scientifiche, derivate dall’aderenza alle più recenti acquisizioni della ricerca internazionale sulla longevità e sulla prevenzione delle patologie età-correlate. I protocolli adottati integrano evidenze cliniche validate, modelli biologici dell’invecchiamento e linee guida aggiornate delle principali società mediche e scientifiche mondiali, garantendo un approccio rigoroso, misurabile e orientato alla prevenzione primaria e secondaria.

Riferimenti Bibliografici Longevità e prevenzione primaria

  1. López-Otín C., et al., The hallmarks of aging: an expanding universe. Cell, 2023.
  2. Kennedy B.K., et al., Geroscience: linking aging to chronic disease. Cell, 2014–2016.
  3. Franceschi C et al., Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 2018.
  4. Horvath S., Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics, 2018.
  5. Levine M.E., et al.An epigenetic biomarker of aging for lifespan and healthspan. Aging, 2018.
  6. Ferrucci L., et al., Time and the metrics of aging. Circulation Research, 2018.
  7. Ferrucci L., et al., Measuring biological aging in humans: a quest. Nature Aging, 2020.
  8. Campisi J., et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature, 2019.
  9. Kirkland J.L., Tchkonia T. Cellular senescence: a translational perspective. EBioMedicine, 2017.
  10. Niccoli T., Partridge L. Ageing as a risk factor for disease. Current Biology, 2012.
  11. Longo V.D., Anderson R.M. Nutrition, longevity and disease: from molecular mechanisms to interventions. Cell, 2022.
  12. Fontana L., Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell, 2015.
  13. Mattson M.P., et al., Impact of intermittent fasting on health and disease processes. Ageing Research Reviews, 2017.
  14. Mattson M.P., et al. Effects of intermittent fasting on health, aging, and disease. NEJM, 2019.
  15. de Cabo R., et al.,. Effects of intermittent fasting on health, aging, and disease. NEJM, 2019.
  16. Barzilai N., et al. Metformin as a tool to target aging. Cell Metabolism, 2016.
  17. Blagosklonny M.V. From rapamycin to anti-aging medicine. Cell Cycle, 2010.
  18. Johnson S.C., et al.,  mTOR is a key modulator of ageing and age-related disease. Nature, 2013.
  19. Belsky D.W., et al.,  Quantification of biological aging in young adults. PNAS, 2015.
  20. Christensen K., et al.,   Ageing populations: the challenges ahead. The Lancet, 2009.
  21. Vaupel J.W., et al.,  Demography of human longevity. Science, 2021.
  22. Seals D.R., et al., Physiology of healthy aging: insights from exercise science.
    Journal of Physiology, 2016.
  23. Booth F.W., et al., Lack of exercise is a major cause of chronic diseases. Comprehensive Physiology, 2017.
  24. Milman S., et al., Low insulin-like growth factor-1 is associated with exceptional longevity.
    JAMA, 2014.
  25. Rea I.M., et al. Age and age-related diseases: role of inflammation. Ageing Research Reviews, 2018.
  26. Cummings J., et al. Alzheimer’s disease drug development pipeline. Alzheimer’s & Dementia, 2020.
  27. Kivimäki Met al. Overweight, obesity, and risk of cardiometabolic multimorbidity. BMJ, 2017.
  28. Sierra F., Advances in geroscience. Cold Spring Harbor Perspectives in Medicine, 2017.
  29. World Health Organization (WHO). World Report on Ageing and Health. WHO Press, 2015.

World Health Organization (WHO). Decade of Healthy Ageing 2021–2030: Baseline Report.
WHO, 2020–2021.

Associazioni mediche e scientifiche di riferimento